1. Home
  2. NRC vs DNA Comparison

NRC vs DNA Comparison

Compare NRC & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo National Research Corporation (Delaware)

NRC

National Research Corporation (Delaware)

HOLD

Current Price

$17.13

Market Cap

390.8M

Sector

Health Care

ML Signal

HOLD

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

HOLD

Current Price

$5.93

Market Cap

455.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NRC
DNA
Founded
1981
2008
Country
United States
United States
Employees
N/A
485
Industry
Biotechnology: Commercial Physical & Biological Resarch
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
390.8M
455.8M
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
NRC
DNA
Price
$17.13
$5.93
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
$8.50
AVG Volume (30 Days)
100.0K
1.2M
Earning Date
04-27-2026
05-05-2026
Dividend Yield
3.65%
N/A
EPS Growth
4707.69
N/A
EPS
50.00
N/A
Revenue
$119,686,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$0.35
N/A
Revenue Growth
1.81
N/A
52 Week Low
$9.76
$5.00
52 Week High
$22.79
$17.58

Technical Indicators

Market Signals
Indicator
NRC
DNA
Relative Strength Index (RSI) 56.29 36.90
Support Level $14.78 N/A
Resistance Level $18.29 $10.05
Average True Range (ATR) 0.91 0.47
MACD 0.15 0.04
Stochastic Oscillator 52.12 5.07

Price Performance

Historical Comparison
NRC
DNA

About NRC National Research Corporation (Delaware)

National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. The company operates in the United States and Canada, of which key revenue is derived from the United States.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: